Abstract:Abstract Inflammatory bowel disease (IBD) is a spectrum of disorders, namely Crohn’s Disease (CD) and Ulcerative Colitis (UC), characterized by distinct patterns of intestinal inflammation, a dysregulated intestinal immune response, and an altered gut microbiota. Given the growing number of new IBD diagnoses (70,000 new cases reported each year) and the inconsistent results of current treatment options, there is a major unmet need to understand IBD pathophysiology to develop more effective treatments. Previous reports indicate that IBD patients have an altered gut microbiota that can influence the development of inflammatory innate and adaptive immune cells that cause intestinal tissue damage and drive IBD pathogenesis. In particular, innate-like γδ T cells have been shown to accumulate within lesional tissue of CD patients and exhibit an inflammatory profile. However, the role of γδ T cells in promoting CD is not well understood, partially due to a lack of mouse models that accurately mimic human γδ T cell phenotypes. Thus, there is a critical need to more deeply understand conventional-γδ cross-talk in the intestine and develop novel animal models that accurately recapitulate these interactions during disease. We have previously shown that the transcription factors (TFs) STAT3 and BATF play critical roles in pathogenic CD4 T cell differentiation, but their roles in modulating interactions between adaptive and innate-like T cells are less clear. In our preliminary work, we surprisingly found that mice with conventional T cell-specific deletions in STAT3 and BATF, but not each individual TF, developed an aggressive spontaneous colitis with pathology that mimics the intestinal damage seen in Crohn’s disease patients. This spontaneous colitis was hallmarked by elevated numbers of inflammatory (i.e., high IFN-γ producing) γδ T cells in the intestines, which mimic those found in a subset of IBD patients. Importantly, depletion of γδ T cells in this model resulted in diminished disease, implicating these cells as key mediators of CD-like intestinal inflammation. γδ T cells in our model were largely localized between colonic crypts and in close proximity to the gut microbiota, suggesting that they may be influenced by changes in gut microbes. Indeed, we observed that STAT3/BATF-deficient mice exhibited an altered gut microbiota which was required for the dysregulated γδ T cell response. Taken together, our data indicate that STAT3/BATF-expressing conventional CD4 T cells regulate gut microbes that would otherwise drive the generation of inflammatory γδ T cells that contribute to CD-like disease. Therefore, a better understanding of microbe-γδ T cell interactions is imperative for understanding intestinal homeostasis and for defining therapies that may prevent the onset of IBD. Figure 1 Graphical abstract. This project seeks to identify the interactions between T cells and gut microbiota in driving IBD, more specifically Crohn’s disease.

A Novel Crosstalk Between TLR4- and NOD2-mediated Signaling in the Regulation of Intestinal Inflammation

A Protective Role of NOD2 on Oxazolone-induced Intestinal Inflammation Through IL-1β-mediated Signalling Pathway

Innate immune mechanisms of colitis and colitis-associated colorectal cancer

NOD2 Regulates CXCR3-dependent CD8+ T Cell Accumulation in Intestinal Tissues with Acute Injury.

A Novel Function of the Crohn’s Disease—associated Nod2 Mutant 1007 Fs in the Regulation of Human IL10 Gene Transcription

Recognition of Gut Microbiota by NOD2 is Essential for the Homeostasis of Intestinal Intraepithelial Lymphocytes.

NOD2-mediated dual negative regulation of inflammatory responses triggered by TLRs in the gastrointestinal tract

Crosstalk Between The Immune Receptors and Gut Microbiota

Transcriptional modulation of pattern recognition receptors in acute colitis in mice

Toll-Like Receptor 2 Deficiency Exacerbates Dextran Sodium Sulfate-Induced Intestinal Injury through Marinifilaceae- Dependent Attenuation of Cell Cycle Signaling

P011 New insights into the pathogenic potential and signalling network of NKG2D+ CD4+ T-cells in Crohn’s Disease

Reciprocal Cross-Talk Between Nod2 and TAK1 Signaling Pathways.

The Role of NOD2 in Intestinal Immune Response and Microbiota Modulation: A Therapeutic Target in Inflammatory Bowel Disease.

A NOVEL MOUSE MODEL OF CROHN’S DISEASE DRIVEN BY THE INTERACTION OF CD4 T CELLS AND GUT MICROBIOTA-RESPONSIVE γδ T CELLS

The Protective Role of TLR4 in Intestinal Epithelial Cells through the Regulation of the Gut Microbiota in DSS-Induced Colitis in Mice

Delineating the Role of Toll-Like Receptors in Inflammatory Bowel Disease.

NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host-Gut Microbiota Interactions during Inflammatory Bowel Disease

Activation of Both TLR and NOD Signaling Confers Host Innate Immunity-Mediated Protection Against Microbial Infection

Lymphotoxin-Dependent Control of Intestinal Inflammation

Activation of nucleotide-binding oligomerization domain 2 by muramyl dipeptide negatively regulates Toll-like receptor 9-mediated colonic inflammation through the induction of deubiquitinating enzyme A expression

Role of Nod2 in the development of Crohn's disease